AryoTrust® (Trastuzumab) Safety Study
NCT06021379
·
clinicaltrials.gov ↗
COMPLETED
Status
597
Enrollment
INDUSTRY
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Trastuzumab
Sponsor
AryoGen Pharmed Co.